BACKGROUND: For many patients with lung cancer, disease progression occurs without notice or with vague symptoms, and unfortunately, most treatments are not curative. Given this unpredictability, we hypothesized the following: (1) poorer psychological adjustment (specifically, more depressive symptoms, higher perceptions of stress, and poorer emotional well-being) would be associated with higher intolerance for uncertainty, higher perceived illness-related ambiguity, and their interaction; and (2) greater avoidance would mediate associations between higher intolerance of uncertainty and poorer psychological adjustment. METHODS: Participants (N = 49) diagnosed with lung cancer at least 6 months prior to enrollment completed the Center for Epidemiologic Studies - Depression Scale, the Functional Assessment of Cancer Therapy - Lung Emotional Well-being subscale, the Perceived Stress scale, the Intolerance of Uncertainty scale, the Mishel Uncertainty in Illness Scale Ambiguity subscale, the Impact of Event - Revised Avoidance subscale, and the Short-scale Eysenck Personality Questionnaire - Revised Neuroticism subscale. Mean age was 64.2 years (standard deviation [SD] = 11.0), mean years of education was 15.6 (SD = 3.1), and 71.4% were female. Hypotheses were tested with regression analyses, adjusted for neuroticism. RESULTS: Higher perceptions of stress and poorer emotional well-being were associated with higher levels of intolerance of uncertainty and higher perceived illness-related ambiguity. Non-somatic depressive symptoms were associated with higher levels of intolerance of uncertainty. Avoidance was found to mediate relations of intolerance of uncertainty with non-somatic depressive symptoms and emotional well-being only. CONCLUSIONS: Findings suggest that interventions to address avoidance and intolerance of uncertainty in individuals with lung cancer may help improve psychological adjustment.
BACKGROUND: For many patients with lung cancer, disease progression occurs without notice or with vague symptoms, and unfortunately, most treatments are not curative. Given this unpredictability, we hypothesized the following: (1) poorer psychological adjustment (specifically, more depressive symptoms, higher perceptions of stress, and poorer emotional well-being) would be associated with higher intolerance for uncertainty, higher perceived illness-related ambiguity, and their interaction; and (2) greater avoidance would mediate associations between higher intolerance of uncertainty and poorer psychological adjustment. METHODS:Participants (N = 49) diagnosed with lung cancer at least 6 months prior to enrollment completed the Center for Epidemiologic Studies - Depression Scale, the Functional Assessment of Cancer Therapy - Lung Emotional Well-being subscale, the Perceived Stress scale, the Intolerance of Uncertainty scale, the Mishel Uncertainty in Illness Scale Ambiguity subscale, the Impact of Event - Revised Avoidance subscale, and the Short-scale Eysenck Personality Questionnaire - Revised Neuroticism subscale. Mean age was 64.2 years (standard deviation [SD] = 11.0), mean years of education was 15.6 (SD = 3.1), and 71.4% were female. Hypotheses were tested with regression analyses, adjusted for neuroticism. RESULTS: Higher perceptions of stress and poorer emotional well-being were associated with higher levels of intolerance of uncertainty and higher perceived illness-related ambiguity. Non-somatic depressive symptoms were associated with higher levels of intolerance of uncertainty. Avoidance was found to mediate relations of intolerance of uncertainty with non-somatic depressive symptoms and emotional well-being only. CONCLUSIONS: Findings suggest that interventions to address avoidance and intolerance of uncertainty in individuals with lung cancer may help improve psychological adjustment.
Authors: Laura A Petrillo; Lara N Traeger; Robert K Sommer; Ashley Z Zhou; Jennifer S Temel; Joseph A Greer Journal: J Cancer Surviv Date: 2021-03-09 Impact factor: 4.442
Authors: Hung-Jui Tan; Leonard S Marks; Michael A Hoyt; Lorna Kwan; Christopher P Filson; Malu Macairan; Patricia Lieu; Mark S Litwin; Annette L Stanton Journal: J Urol Date: 2016-02-09 Impact factor: 7.450
Authors: Charlene M Fares; Timothy J Williamson; Matthew K Theisen; Amy Cummings; Krikor Bornazyan; James Carroll; Marshall L Spiegel; Annette L Stanton; Edward B Garon Journal: JCO Clin Cancer Inform Date: 2018-12
Authors: Jacqueline Jones; Carolyn T Nowels; Rebecca Sudore; Sangeeta Ahluwalia; David B Bekelman Journal: J Gen Intern Med Date: 2014-11-11 Impact factor: 5.128
Authors: Karin F Hoth; Frederick S Wamboldt; Dee W Ford; Robert A Sandhaus; Charlie Strange; David B Bekelman; Kristen E Holm Journal: Int J Behav Med Date: 2015-04
Authors: Lindsey A Torbit; Jenna J Albiani; Melyssa Aronson; Spring Holter; Kara Semotiuk; Zane Cohen; Tae L Hart Journal: J Behav Med Date: 2016-01-13
Authors: Nicci Bartley; Christine E Napier; Zoe Butt; Timothy E Schlub; Megan C Best; Barbara B Biesecker; Mandy L Ballinger; Phyllis Butow Journal: Front Psychol Date: 2021-04-22